Cookie Policy

This site uses cookies. When browsing the site, you are consenting its use. Learn more

I understood

The European rabbit IgA's as a model for therapeutic antibodies development: a genomic and functional approach.

The European rabbit IgA's as a model for therapeutic antibodies development: a genomic and functional approach.

With 13 IgA subclasses the European rabbit (Oryctolagus cuniculus) has the most complex IgA system of all studied mammals. Moreover, our studies of three wild rabbits have revealed six additional copies of rabbit IgA genes. Additionally, the rabbit has lost FcalphaRI, the prototypic IgA FcR, and hence rabbit IgA's must use alternative receptors. This makes the European rabbit an incomparable source of IgA's natural variation coupled to the fact that uncovering which FcR's are used may contribute to finding valuable alternative pathways. With this project we plan to i) characterize the genetic diversity of European rabbit IgA, ii) identify which FcR's are used by rabbit IgA subclasses, and iii) explore the functional capabilities of selected rabbit IgA subclasses and of engineered human IgG and IgA incorporating selected rabbit hinge sequences.

Team
Principal Investigator
Ana Pinheiro

Ana Pinheiro

Position: Post-Doc Researcher
Group:
IMED
View
Researchers
Pedro José Esteves

Pedro José Esteves

Position: Principal Researcher
Group:
IMED
View
Tereza Almeida

Tereza Almeida

Position: Post-Doc Researcher
Group:
IMED
View
Other members
Jenny M. Woof (University of Dundee, U.K.), Katherine L. Knight and Dennis K. Lanning (Loyola University Chicago, U.S.A.)
State
Ongoing
Proponent Institution
ICETA-UP (CIBIO-InBIO)
Funded by
FCT
Dates
2018 (Duration: 2 years)
Participant Institutions
CIBIO-InBIO, Loyola University Chicago, U.K., U.S.A., University of Dundee
Reference
02966-02/SAICT/2017
Share this: